U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07118813) titled 'Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment' on Aug. 05.
Brief Summary: This is a prospective observational cohort study (AI-Kidney-Prognosis), aiming to non-invasively predict the clinical outcomes in renal cell carcinoma patients after surgical treatment using radiomics-based AI models, thereby assisting clinical decision-making and personalized follow-up strategies.
Study Start Date: Aug., 2025
Study Type: OBSERVATIONAL
Condition:
Renal Cell Carcinoma (Kidney Cancer)
Recruitment Status: RECRUITING
Sponsor: Union Hospital, Tongji Medic...